Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Boutron

Showing results (91-100 of 291) with videos related to

Pageof 30
Sort By:
BMJ (Clinical Research Ed.)|November 19, 2009
Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic reviewLeslie Pibouleau, Isabelle Boutron, Barnaby C Reeves, et al.
Systematic Reviews|February 21, 2024
Synthesis methods used to combine observational studies and randomised trials in published meta-analysesCherifa Cheurfa, Sofia Tsokani, Katerina-Maria Kontouli, et al.
JAMA|August 14, 2014
Association between analytic strategy and estimates of treatment outcomes in meta-analysesAgnes Dechartres, Douglas G Altman, Ludovic Trinquart, et al.
BMJ Evidence-Based Medicine|February 20, 2025
Post-publication peer review and the identification of methodological and reporting issues in COVID-19 trials: a qualitative studyMauricia Davidson, Christoffer Bruun Korfitsen, Carolina Riveros, et al.
European Heart Journal|October 15, 2005
Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolismGabriel Thabut, Candice Estellat, Isabelle Boutron, et al.
Trials|May 6, 2009
Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary interventionMorgane Ethgen, Isabelle Boutron, Philippe Gabriel Steg, et al.
The Cochrane Database of Systematic Reviews|June 4, 2013
Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challengeAsbjørn Hróbjartsson, Isabelle Boutron, Lucy Turner, et al.
Journal of Medical Internet Research|February 1, 2022
Patients' Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based SurveyVan Thu Nguyen, Philippe Ravaud, Viet Thi Tran, et al.
Presse Medicale (Paris, France : 1983)|April 24, 2004
[Rehabilitation on effort of low back pain. Functional restoration programs]Serge Poiraudeau, François Rannou, Marie Martine Lefevre Colau, et al.
Annals of Internal Medicine|July 7, 2005
Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic diseaseMorgane Ethgen, Isabelle Boutron, Gabriel Baron, et al.
Pageof 30

Showing results (91-100 of 291) with videos related to

Sort By:
Pageof 30
BMJ (Clinical Research Ed.)|November 19, 2009
Applicability and generalisability of published results of randomised controlled trials and non-randomised studies evaluating four orthopaedic procedures: methodological systematic reviewLeslie Pibouleau, Isabelle Boutron, Barnaby C Reeves, et al.
Systematic Reviews|February 21, 2024
Synthesis methods used to combine observational studies and randomised trials in published meta-analysesCherifa Cheurfa, Sofia Tsokani, Katerina-Maria Kontouli, et al.
JAMA|August 14, 2014
Association between analytic strategy and estimates of treatment outcomes in meta-analysesAgnes Dechartres, Douglas G Altman, Ludovic Trinquart, et al.
BMJ Evidence-Based Medicine|February 20, 2025
Post-publication peer review and the identification of methodological and reporting issues in COVID-19 trials: a qualitative studyMauricia Davidson, Christoffer Bruun Korfitsen, Carolina Riveros, et al.
European Heart Journal|October 15, 2005
Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolismGabriel Thabut, Candice Estellat, Isabelle Boutron, et al.
Trials|May 6, 2009
Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary interventionMorgane Ethgen, Isabelle Boutron, Philippe Gabriel Steg, et al.
The Cochrane Database of Systematic Reviews|June 4, 2013
Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challengeAsbjørn Hróbjartsson, Isabelle Boutron, Lucy Turner, et al.
Journal of Medical Internet Research|February 1, 2022
Patients' Perspectives on Transforming Clinical Trial Participation: Large Online Vignette-based SurveyVan Thu Nguyen, Philippe Ravaud, Viet Thi Tran, et al.
Presse Medicale (Paris, France : 1983)|April 24, 2004
[Rehabilitation on effort of low back pain. Functional restoration programs]Serge Poiraudeau, François Rannou, Marie Martine Lefevre Colau, et al.
Annals of Internal Medicine|July 7, 2005
Reporting of harm in randomized, controlled trials of nonpharmacologic treatment for rheumatic diseaseMorgane Ethgen, Isabelle Boutron, Gabriel Baron, et al.
Pageof 30